Errazquin R., Page A., Suñol A., Segrelles C., Carrasco E., Peral J., Garrido-Aranda A., Del Marro S., Ortiz J., Lorz C., Minguillon J., Surralles J., Belendez C., Alvarez M., Balmaña J., Bravo A., Ramirez A., Garcia-Escudero R.. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia. ORAL ONCOLOGY. 2022; 134DOI:10.1016/j.oraloncology.2022.106184. PMID:36191479. IF:4.800(Q1/1D).

Sevilla, J, Navarro, S, Rio, P, Sanchez-Dominguez, R, Zubicaray, J, Galvez, E, Merino, E, Sebastian, E, Azqueta, C, Casado, JA, Segovia, JC, Alberquilla, O, Bogliolo, M, Roman-Rodriguez, FJ, Gimenez, Y, Larcher, L, Salgado, R, Pujol, RM, Hladun, R, Castillo, A, Soulier, J, Querol, S, Fernandez, J, Schwartz, J, de Andoin, NG, Lopez, R, Catala, A, Surralles, J, Diaz-de-Heredia, C, Bueren, JA. Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes. Molecular Therapy-Methods & Clinical Development. 2021; 22DOI:10.1016/j.omtm.2021.06.001. PMID:34485595. IF:5.849(Q2/4D).

Castells-Roca, L, Gutierrez-Enriquez, S, Bonache, S, Bogliolo, M, Carrasco, E, Aza-Carmona, M, Montalban, G, Munoz-Subirana, N, Pujol, R, Cruz, C, Llop-Guevara, A, Ramirez, MJ, Saura, C, Lasa, A, Serra, V, Diez, O, Balmana, J, Surralles, J. Clinical consequences of BRCA2 hypomorphism. npj Breast Cancer. 2021; 7(1)DOI:10.1038/s41523-021-00322-9. PMID:34504103. IF:7.519(Q1/3D).

Isla, D, de Castro, J, Garcia-Campelo, R, Majem, M, Vicente, D, Juan-Vidal, O. Treatment strategy optimization for patients with non-small-cell lung cancer harboring EGFR mutation: a Delphi consensus. Clinical & Translational Oncology. 2021; 23(7)DOI:10.1007/s12094-020-02518-0. PMID:33210237. IF:3.340(Q3/7D).